Dare Bioscience (DARE) vs Vyome (HIND)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Dare Bioscience (DARE) has outperformed Vyome (HIND) over the past year, losing 64.8% versus a loss of 67.1%. Over five years, DARE leads with a -95.8% price change compared with -100.0% for HIND. Dare Bioscience is the larger company by market cap ($14.9 million vs $14.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DARE | HIND |
|---|---|---|
| Share price | $0.7556 | $1.99 |
| Market cap | $14.86M | $13.97M |
| 1-day change | -4.35% | -2.45% |
| YTD return | -59.07% | -40.70% |
| 1-year return | -64.81% | -67.15% |
| 5-year return | -95.81% | -100.00% |
| P/E ratio (TTM) | — | 1.12 |
| EPS (TTM) | $-0.71 | $1.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.78 | $6.56 |
| 52-week low | $0.69 | $1.75 |
| Distance from 52-week high | -80.01% | -69.66% |
| Average volume | 524.37K | 13.60K |
| Shares outstanding | 19.67M | 7.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DARE vs HIND FAQ
Which is bigger, Dare Bioscience or Vyome?
Dare Bioscience (DARE) is larger, with a market capitalization of $14.86M compared with $13.97M for Vyome (HIND).
Which stock has performed better over the past year, DARE or HIND?
DARE returned -64.81% over the past 12 months, compared with -67.15% for HIND (price return, excluding dividends). Past performance does not predict future results.
Are Dare Bioscience and Vyome in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.